Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Seeger

Showing results (61-70 of 155) with videos related to

Pageof 16
Sort By:
Progress in Clinical and Biological Research|January 1, 1994
Myeloablative chemoradiotherapy versus continued chemotherapy for high risk neuroblastomaD O Stram, K K Matthay, M O'Leary, et al.
The American Journal of Pathology|January 1, 1997
Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridizationD Plantaz, G Mohapatra, K K Matthay, et al.
Progress in Clinical and Biological Research|January 1, 1988
N-myc protein expression by neuroblastoma cells that have metastasized to bone marrowT J Moss, Y M Law, D J Slamon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Escalating dose of continuous infusion combination chemotherapy for refractory neuroblastomaL A Campbell, R C Seeger, R E Harris, et al.
Journal of the National Cancer Institute|July 7, 1999
Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell linesB J Maurer, L S Metelitsa, R C Seeger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1989
Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapyK K Matthay, H N Sather, R C Seeger, et al.
Progress in Clinical and Biological Research|January 1, 1985
Sensitive detection of neuroblastoma cells in bone marrow for monitoring the efficacy of marrow purging proceduresC P Reynolds, T J Moss, R C Seeger, et al.
Cancer Research|November 1, 1986
Model system for removing neuroblastoma cells from bone marrow using monoclonal antibodies and magnetic immunobeadsC P Reynolds, R C Seeger, D D Vo, et al.
Progress in Clinical and Biological Research|January 1, 1988
Molecular analysis and clinical significance of N-myc amplification and chromosome 1p monosomy in human neuroblastomasG M Brodeur, C T Fong, M Morita, et al.
Cancer|September 15, 1991
A significant association of Ha-ras p21 in neuroblastoma cells with patient prognosis. A retrospective study of 103 casesT Tanaka, D J Slamon, H Shimada, et al.
Pageof 16

Showing results (61-70 of 155) with videos related to

Sort By:
Pageof 16
Progress in Clinical and Biological Research|January 1, 1994
Myeloablative chemoradiotherapy versus continued chemotherapy for high risk neuroblastomaD O Stram, K K Matthay, M O'Leary, et al.
The American Journal of Pathology|January 1, 1997
Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridizationD Plantaz, G Mohapatra, K K Matthay, et al.
Progress in Clinical and Biological Research|January 1, 1988
N-myc protein expression by neuroblastoma cells that have metastasized to bone marrowT J Moss, Y M Law, D J Slamon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Escalating dose of continuous infusion combination chemotherapy for refractory neuroblastomaL A Campbell, R C Seeger, R E Harris, et al.
Journal of the National Cancer Institute|July 7, 1999
Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell linesB J Maurer, L S Metelitsa, R C Seeger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1989
Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapyK K Matthay, H N Sather, R C Seeger, et al.
Progress in Clinical and Biological Research|January 1, 1985
Sensitive detection of neuroblastoma cells in bone marrow for monitoring the efficacy of marrow purging proceduresC P Reynolds, T J Moss, R C Seeger, et al.
Cancer Research|November 1, 1986
Model system for removing neuroblastoma cells from bone marrow using monoclonal antibodies and magnetic immunobeadsC P Reynolds, R C Seeger, D D Vo, et al.
Progress in Clinical and Biological Research|January 1, 1988
Molecular analysis and clinical significance of N-myc amplification and chromosome 1p monosomy in human neuroblastomasG M Brodeur, C T Fong, M Morita, et al.
Cancer|September 15, 1991
A significant association of Ha-ras p21 in neuroblastoma cells with patient prognosis. A retrospective study of 103 casesT Tanaka, D J Slamon, H Shimada, et al.
Pageof 16